2m 2m 2m 2m 2m 2m 2m
SONOMA PHARMA (SNOA)
NASDAQ
$1.11-$0.03 (-2.54%)
Price as of Jun 23, 2026 7:57 PM EDT- $4.0MMarket Cap
- -60.82%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SONOMA PHARMA (SNOA)
$1.11-$0.03 (-2.54%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 19.5M +36.68% | 14.3M +12.19% | 12.7M -4.05% | 13.3M +5.10% | |
Cost of Revenue | 12.1M +37.30% | 8.8M +10.43% | 8.0M -9.15% | 8.8M +1.85% | |
Gross Profit | 7.4M +35.68% | 5.5M +15.17% | 4.7M +5.99% | 4.5M +12.12% | |
Sales and Marketing Expense | 7.6M +3.31% | 7.4M -2.83% | 7.6M -14.31% | 8.8M -9.38% | |
Research and Development Expense | -2.3M +25.19% | -1.8M -3.05% | -1.9M +803.86% | -207,000 +65.60% | |
Depreciation and Amortization Expense | 139,000 +0.72% | 138,000 -21.59% | 176,000 +40.80% | 125,000 -32.80% | |
Total Operating Expenses | 9.9M +7.64% | 9.2M -2.87% | 9.4M +4.41% | 9.0M -8.43% | |
Operating Profit | -2.5M -33.67% | -3.7M -21.08% | -4.7M +2.87% | -4.6M -22.37% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | 16,000 +260.00% | |
Income before Taxes | -3.4M +17.61% | -2.9M -42.22% | -5.0M -2.95% | -5.2M -4.32% | |
Income Taxes | -244,000 -144.36% | 550,000 +380.61% | -196,000 +493.94% | -33,000 -90.06% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | N/A N/A | -161,000 -96.67% | -4.8M -6.13% | -5.2M +1.28% | |
Net Income from Continuing Operations Applicable to Common | -3.4M +17.61% | -2.9M -42.22% | -5.0M -2.95% | -5.2M -4.32% | |
Basic EPS and Net Income | -1.89 -32.26% | -2.79 +426.42% | -0.53 -65.13% | -1.52 N/A | |
Diluted EPS and Net Income | -1.89 -32.26% | -2.79 +426.42% | -0.53 -65.13% | -1.52 N/A | |
Basic Weighted Average Shares | 1.7M +35.70% | 1.2M -86.35% | 9.1M +267,725.57% | 3,394 -99.87% | |
Diluted Weighted Average Shares | 1.7M +35.70% | 1.2M -86.35% | 9.1M +267,725.57% | 3,394 -99.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.4M -55.36% | 5.4M +71.80% | 3.1M -18.12% | 3.8M -48.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.4M -55.36% | 5.4M +71.80% | 3.1M -18.12% | 3.8M -48.35% | |
Total Current Assets | 12.1M -4.33% | 12.6M +0.80% | 12.5M -9.06% | 13.8M -16.02% | |
Accumulated Depreciation | 2.5M +19.52% | 2.1M -12.82% | 2.4M +18.17% | 2.0M +17.71% | |
Property and Plant and Equipment and Net | 310,000 +37.78% | 225,000 -38.36% | 365,000 -25.20% | 488,000 +52.50% | |
Total Long-Term Assets | 64,000 -13.51% | 74,000 +12.12% | 66,000 -9.59% | 73,000 -5.19% | |
Total Assets | 14.0M +1.95% | 13.7M -7.10% | 14.7M -9.19% | 16.2M -13.87% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 222,000 +0.91% | 220,000 -31.89% | 323,000 -25.06% | 431,000 -46.66% | |
Total Current Liabilities | 4.8M +17.97% | 4.1M +10.14% | 3.7M +0.05% | 3.7M -36.12% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Long-Term Liabilities | 469,000 +965.91% | 44,000 -74.71% | 174,000 -42.38% | 302,000 -38.49% | |
Total Liabilities | 10.9M +17.05% | 9.3M +7.89% | 8.6M +4.23% | 8.3M -18.66% | |
Retained Earnings | -201.0M +1.61% | -197.8M +1.78% | -194.3M +2.55% | -189.5M +2.79% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 6.1M -23.07% | 8.0M -8.28% | |
Total Shares Outstanding | 1.8M +10.08% | 1.6M -89.53% | 15.6M +216.35% | 4.9M +59.10% | |
Cash Flow | |||||
Cash from Operating Activities | -3.9M +4,369.32% | -88,000 -96.33% | -2.4M -61.02% | -6.2M +44.82% | |
Capital Expenditures | 192,000 +140.00% | 80,000 +370.59% | 17,000 -93.68% | 269,000 +96.35% | |
Cash from Investing Activities | -192,000 +140.00% | -80,000 +3,900.00% | -2,000 -99.22% | -258,000 +160.61% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 477,000 -84.26% | 3.0M +80.79% | 1.7M -32.66% | 2.5M -66.35% | |
Financials Ratio | |||||
Gross Margin | 37.97% -0.73% | 38.25% +2.66% | 37.26% +10.46% | 33.73% +6.68% | |
Operating Margin | -12.60% -51.47% | -25.97% -29.66% | -36.91% +7.20% | -34.43% -26.14% | |
Return on Assets | N/A N/A | -1.13% -96.37% | -31.22% +6.31% | -29.37% -2.31% | |
Return on Equity | N/A N/A | N/A N/A | -68.51% +10.89% | -61.78% -14.60% | |
Revenue Growth | 36.68% +200.80% | 12.19% +401.39% | -4.05% -179.34% | 5.10% +115.83% | |
Current Ratio | 2.50 -18.91% | 3.09 -8.48% | 3.37 -9.11% | 3.71 +31.47% | |
Cash Ratio | 0.50 -62.16% | 1.31 +55.99% | 0.84 -18.16% | 1.03 -19.14% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.05 -41.87% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.03 -38.00% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow